Studies in adults examining differences in NAFLD prevalence based on menopausal status, use of synthetic hormones, puberty onset, and conditions causing disrupted sex hormone levels, such as polycystic ovary syndrome (PCOS), strongly suggest that sex hormones may play a role in the development of NAFLD [5–7]. Here, PLXNA3 is linked to metabolic dysfunction-associated steatotic liver disease.